Stay ahead of the markets with Dylan's daily insights, breaking news analysis, and curated morning watchlists.
Breaking news and analysis from the financial markets
Mid-February, we made an argument for $3,000+ gold. We also highlighted two exchange-traded funds as a way to trade gold upside. Today, with the metal now up to $3,033, those two ETFs are rocketing...
Fear eventually leads to opportunity. Look at cruise stocks, for example. Over the last few weeks, most of the top cruise stocks were crushed by consumer spending, and potential tax crackdown fears....
Defense stocks could go ballistic in coming days. For one, Europe increasing its defense efforts with the Ukraine-Russia war. Two, with President Trump pounding away at the Houthis and potentially...
Watch THIS Before Gold Moves Again Starting March 18th , a major shift could send gold soaring — or crashing . Either way this shift goes... My one-stock gold strategy is built to show you how to...
Insiders are still aggressively buying stock. Look at Chipotle (SYM: CMG), for example. After dropping from about $67 to a recent low of $48.73, which puts CMG at triple bottom support dating back to...
Make smarter, more informed investment choices? Get Daily Actionable Stock Picks Straight to Your Inbox! Keep an eye on the Volatility Index (VIX), we said in early February. In fact, on February 4,...
Keep an eye on the stretched Volatility Index (VIX). It’s now at its second highest point over the last year. It’s also stretched on RSI, MACD and Williams’ %R. Also, historically, when the VIX gets...
Sometimes the best opportunities can be found in severely beaten down stocks. Especially when insiders are buying the pullbacks. Look at rebounding shares of Akamai Technologies (SYM: AKAM). After...
Remember to always keep an eye on insider buying. Here’s where insiders have been putting their money where their mouths are. Ameresco (SYM: AMRC) On March 6, President and CEO George Sekellaris...
It’s time to buy down, but not out obesity stocks, we said just weeks ago. With more drug trial data expected, related stocks could rocket even higher – especially with obesity rates still bursting...
Showing 501 - 510 of 682 posts
CEO & Chief Analyst
With 30+ years of experience in independent research, Dylan shares daily insights on where Wall Street isn't looking.
Learn More About DylanIn the newspaper
Dylan's weekly column, The Boca Raton Tribune
Is the AI Trade Over?
Read the column (opens in a new tab)Get Market News in your inbox, free